IMCD N.V. to Acquire Megasetia

two professionals shake hands

Specialty chemical distributor IMCD N.V. announced that IMCD Indonesia has signed an agreement to acquire PT Megasetia Agung Kimia in Indonesia. IMCD will acquire 70% of Megasetia’s share capital now and the remaining 30% in 2025.

Megasetia, which was founded in 1995, is a distributor for specialty ingredients for the pharmaceuticals industry. It also covers the personal care, home care, animal health and industrial markets, offering end-to-end solutions to its customers and partners with three laboratories, six offices and six warehouses across Indonesia. According to IMCD, it generated a revenue of approximately EUR 60 million in 2020 and has approximately 160 employees. Megasetia currently serves more than 1,000 customers and represents more than 50 of the world’s leading ingredients producers.

“Indonesia is Southeast Asia’s largest economy, and this acquisition provides excellent growth opportunities to strengthen IMCD’s positioning in the life science segments,” said Haiko Zuidhoff, vice president of IMCD APAC. “In addition, it enables us to enhance our offering to local customers and partners.”

“We are confident that our life science portfolio will complement their offering to customers and suppliers,” added Suryani Hartoyo, president director of Megasetia. “Our culture of growth through market knowledge, technical innovation and high level of services, is very well aligned with IMCD’s strategy.”

Copy link
Powered by Social Snap